Welcome to our dedicated page for Predictmedix news (Ticker: PMEDF), a resource for investors and traders seeking the latest updates and insights on Predictmedix stock.
Predictmedix AI Inc. (PMEDF) is a leading provider of rapid health screening solutions powered by proprietary artificial intelligence (AI). The company recently announced a partnership with KGK Science, a renowned name in clinical research, to advance health research and product development. This collaboration aims to introduce transformative changes in healthcare innovation, particularly in clinical trial efficiency and health product development. By leveraging Predictmedix AI's cutting-edge technologies and KGK Science's expertise, the partnership is set to redefine health assessment methodologies and outcomes.
KGK Science, with over 22 years of experience, is known for its expertise in clinical research and regulatory support for nutraceutical, cannabis, and hemp industries. On the other hand, Predictmedix AI's Safe Entry Stations utilize multispectral cameras to predict a variety of health issues, including vital parameters, drug impairment, fatigue, and mental illnesses. Together, these companies are focused on enhancing health research and product development through innovative technologies and creating impactful advancements in healthcare solutions.
Predictmedix Inc. (CSE:PMED)(OTCQB:PMEDF) has announced a major upgrade to its Safe Entry Stations, a series of AI-powered health screening tools. The new technology will now include non-invasive blood pressure readings, enhancing the ability to detect cardiovascular diseases, the world's leading cause of death. Existing features include temperature, heart rate, respiratory rate, and oxygen saturation monitoring. The integration of Heart Rate Variability (HRV) analysis is also being introduced, providing early indicators of various diseases. Trials for blood oxygen saturation screening are set to commence in India. Dr. Rahul Kushwah, COO of Predictmedix, emphasized the importance of these developments in making healthcare more efficient and accessible. The company aims to partner with global leaders to establish AI-powered health screening as a standard in medical care.
Predictmedix Inc. (CSE:PMED)(OTCQB:PMEDF) announced a purchase order from MGM Healthcare, one of India's largest government hospital groups, for five AI-powered Safe Entry Stations. This order, valued at approximately $500,000 CAD over three years, follows a successful clinical study involving 400 patients, validating the effectiveness of the technology. The Safe Entry Stations offer rapid, non-invasive health screenings, enhancing efficiency and patient care in healthcare settings. Dr. Rahul Kushwah emphasized the opportunity for expansion in South Asia and ASEAN countries, where the technology could significantly improve healthcare outcomes.
FAQ
What is the current stock price of Predictmedix (PMEDF)?
What is the market cap of Predictmedix (PMEDF)?
What is Predictmedix AI Inc. known for?
Who is KGK Science and what expertise do they bring to the partnership?
What are the key focus areas of the partnership between Predictmedix AI Inc. and KGK Science?
How do Predictmedix AI's Safe Entry Stations contribute to the partnership?
What are the expected outcomes of the collaboration between Predictmedix AI Inc. and KGK Science?
